🇺🇸 FDA
Patent

US 11744831

Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

granted A61KA61K31/4045A61K31/513

Quick answer

US patent 11744831 (Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections) held by United States Government as represented by the Department of Veterans Affairs expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4045, A61K31/513, A61K31/519, A61K31/52